Dysregulation of miRNAs Levels in Glycogen Synthase Kinase-3β Overexpressing Mice and the Role of miR-221-5p in Synaptic Function

Neuroscience. 2022 May 10:490:287-295. doi: 10.1016/j.neuroscience.2022.03.024. Epub 2022 Mar 21.

Abstract

Glycogen synthase kinase-3β (GSK-3β) is a highly expressed kinase in the brain, where it has an important role in synaptic plasticity. Aberrant activity of GSK-3β leads to synaptic dysfunction which results in the development of several neuropsychiatric and neurological diseases. Notably, overexpression of constitutively active form of GSK-3β (GSK-3β[S9A]) in mice recapitulates the cognitive and structural defects characteristic for neurological and psychiatric disorders. However, the mechanisms by which GSK-3β regulates synaptic functions are not clearly known. Here, we investigate the effects of GSK-3β overactivity on neuronal miRNA expression in the mouse hippocampus. We found that GSK-3β overactivity downregulates miRNA network with a potent effect on miR-221-5p (miR-221*). Next, characterization of miR-221* function in primary hippocampal cell culture transfected by miR-221* inhibitor, showed no structural changes in dendritic spine shape and density. Using electrophysiological methods, we found that downregulation of miR-221* increases excitatory synaptic transmission in hippocampal neurons, probably via postsynaptic mechanisms. Thus, our data reveal potential mechanism by which GSK-3β and miRNAs might regulate synaptic function and therefore also synaptic plasticity.

Keywords: GSK-3β; electrophysiology; miRNA; next generation sequencing.

MeSH terms

  • Animals
  • Glycogen Synthase Kinase 3 beta* / metabolism
  • Hippocampus / metabolism
  • Mice
  • MicroRNAs* / metabolism
  • Neuronal Plasticity*
  • Neurons / metabolism

Substances

  • MIRN221 microRNA, mouse
  • MicroRNAs
  • Glycogen Synthase Kinase 3 beta
  • Gsk3b protein, mouse